Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000419963 | SCV000343635 | uncertain significance | not provided | 2016-07-15 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000419963 | SCV000511007 | likely benign | not provided | 2017-02-15 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000122270 | SCV000515256 | likely benign | not specified | 2015-06-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000122270 | SCV000597932 | likely benign | not specified | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086760 | SCV000754528 | benign | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000419963 | SCV001501102 | likely benign | not provided | 2020-12-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030596 | SCV000053274 | likely benign | Thrombocytopenia 1 | 2015-10-02 | no assertion criteria provided | clinical testing | |
ITMI | RCV000122270 | SCV000086495 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV003914875 | SCV004734925 | benign | WAS-related disorder | 2020-07-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |